4CMenB vaccine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Neisseria meningitidis of serogroup B (MenB) is currently responsible for more than 70% of cases of invasive meningococcal… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Review
2015
Review
2015
A mass vaccination campaign with the 4CMenB vaccine (Bexsero®; Novartis Pharmaceutical Canada Inc) was launched in a serogroup B… (More)
  • figure 1
Is this relevant?